The second method used to investigate the possible influence of TP53 on tumor development was an in vitro β–lactamase FRET reporter assay using a stably expressing TP53 reporter vector containing copies of the TP53 binding site cloned from the promoter of the p21 gene. The gene discussed is TP53; the disease is neoplasm.